The largest database of trusted experimental protocols

Kinetex xb c18 column

Manufactured by Phenomenex
Sourced in United States, Germany, United Kingdom

The Kinetex XB-C18 column is a high-performance liquid chromatography (HPLC) column designed for the separation and analysis of a wide range of analytes. The column features a core-shell particle technology that provides efficient separation, high resolution, and fast analysis times. The XB-C18 stationary phase offers excellent peak shape and reproducibility for a variety of applications.

Automatically generated - may contain errors

89 protocols using kinetex xb c18 column

1

Solid-Phase Peptide Synthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protected α-amino acids and Rink Amide MBHA-resin were purchased from Bachem (Bubendorf, Switzerland) and Merck-Novabiochem (Darmstadt, Germany). The protecting groups for the α-amino acids were as follows: Fmoc for α-amino groups; tBu for Tyr; OtBu for Asp; Boc for Lys and Trp; Pbf for Arg; and trityl (Trt) for Asn. Solvents and other chemicals for peptide synthesis and purification were purchased from Sigma–Aldrich (Milan, Italy). Mass spectra of the final products were derived on an API 2000 Applied Biosystem mass spectrometer. RP-HPLC preparative purification was routinely performed on a Shimadzu system equipped with a Shimadzu multiwavelength detector on a Phenomenex Kinetex XB-C18 column (5 μm, 21.2 × 250 mm). The operational flow rate was 30 mL/min. The homogeneity of the products was assessed by analytical RP-HPLC using a Phenomenex Kinetex XB-C18 column (5 μm, 4.6 × 250 mm). The column was connected to a Rheodyne model 7725 injector, a Shimadzu-10 ADsp HPLC system and a Shimadzu SPD-20 A/SPD-20 AV UV-VIS detector set to 220 nm.
+ Open protocol
+ Expand
2

Serum C4 Quantification by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum C4 measurement was performed by LC-MS-MS. C4 was extracted using a salting-out method as previously described [24 (link), 25 (link)]. Serum samples were prepared alongside of authentic C4 standards. Briefly, 100 μL of serum was diluted with 200 μL of distilled water, to which 5 ng of d7-C4 (used as internal standard) and 500 μL of acetonitrile were added. Then, 100 mg of ammonium sulfate was added, tubes vortexed for 1 minute and centrifuged at 2,000 g at 4°C for 5 minutes. The supernatant acetonitrile phase was collected and dried under nitrogen at 35°C. The residues were reconstituted with 200 μL methanol, vortexed for 1 minute, incubated for 10 minutes and centrifuged at 20,000 g for 5 minutes. Clear supernatants were transferred to 250 μL inserts for LC-MS-MS analysis. The LC-MS-MS system consisted of an Agilent UHPLC 1290 LC system coupled to an ABSciex QTRAP 5500 in positive ESI MRM mode. Chromatographic separation was performed using a XB-C18 kinetex column (50 x 3.0 mm, 2.6 μm; Phenomenex) operated at a flow rate of 800 μL/minute and eluted isocratically with a mobile phase consisting of acetonitrile/water (98/2, v/v) with 0.1% trifluoroacetic acid. Quantitation of C4 was achieved by comparing the deuterium-to-protium ratio of the samples with a standard using the Analyst 1.6 software.
+ Open protocol
+ Expand
3

Radiolabeling Procedure for LLP2A Peptide

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals and reagents used in the present study were of highest commercially available purity, and all the solutions were prepared using ultrapure water (18 MV-cm resistivity; Millipore system). The proteasome inhibitor, bortezomib, was purchased from Sigma-Aldrich. LLP2A-CB-TE1A1P (LLP2A) peptide was purchased from Auspep (Tullamarine Victoria, Australia), and all other chemicals used in radiolabeling were purchased from Sigma-Aldrich unless otherwise noted. Copper 64 (t1/2—12.7 h) was produced on a CS-15 biomedical cyclotron at Washington University School of Medicine. Radiochemical purity of the labeled peptide was evaluated by analytical reversed-phase high-performance liquid chromatography (HPLC), that was performed on 1200 Infinity series chromatography system, purchased from Agilent Technologies (Santa Clara, CA). The XB-C18 Kinetex column which was procured from Phenomenex was used with mobile phases of 0.1% TFA in water (aqueous phase) and 0.1% TFA in acetonitrile (organic phase). [18F]FDG was produced in compliance with good manufacturing practices (GMP) by Washington University Cyclotron facility.
+ Open protocol
+ Expand
4

INH Quantification by UPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
INH plasma concentration was measured by high performance liquid chromatography‒tandem mass spectrometry using an ACQUITY UPLC H-Class system (Waters, Watford, UK) with a Kinetex XB-C18 column (2.1×100 mm, Phenomenex, Torrance, CA, USA). The flow rate was 200 µL/min. The mobile phases was isocratic of a mixture of 5 mM ammonium acetate in water (solvent A) and acetonitrile (solvent B). After protein precipitation with 50% Acetonitrile, the plasma samples were mixed with an internal standard (carbamazepine) and centrifuged at 4°C for 10 minutes. Total running time of 7 minutes with injection volume 1 µL for each sample. Drug concentrations were determined using a Xevo TQD (Waters). Quantification was achieved by multiple reaction monitoring in positive ion mode with transitions of m/z 138.20 to 121.10 and m/z 237.03 to 194.03 for INH and the internal standard, respectively. The linear assay range is 2–50 ng/mL (r2=0.99). Intra- and inter-day coefficients of variation are monitored to be lower than 10%.
+ Open protocol
+ Expand
5

Quantitative UHPLC-MS/MS Analysis of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analysis was performed using an ultra-high-performance liquid chromatography coupled with tandem mass spectrometry method (UHPLC─QqQ─MS/MS). Chromatographic separation was carried out with the use of a Kinetex® XB-C18 column (150 × 2.1 mm i.d., particle size 2.6 μm; Phenomenex, Torrance, CA, USA). The mobile phase consisted of 0.1% formic acid and 10 mM ammonium formate in water (A) and 0.1% formic acid in acetonitrile (B). The gradient (at a constant flow of 0.4 mL/min) applied was as follows: 0 min, 5% B; 12 min, 98% B; 14 min, 98% B; and 15 min, 5% B. Return to the initial gradient compositions was performed for 5 min. The injection volume was 2.0 μL. Detection was achieved using a triple quadrupole mass spectrometer (Shimadzu 8050, Kyoto, Japan) equipped with an electrospray ionization (ESI) source. Determination of the substances was carried out in the multiple reaction monitoring (MRM) mode. The following MS parameters were fixed: nebulizing gas flow, 3 L/min; heating gas flow, 10 L/min; interface temperature, 250 °C; desolvation line temperature, 200 °C; heat block temperature, 350 °C; and drying gas flow, 10 L/min. A summary of precursor, product ions, collision energies, Q1–Q3 pre bias voltages and retention time for each compound are presented in Table 1.
+ Open protocol
+ Expand
6

UPLC Analysis of Ginger and Standards

Check if the same lab product or an alternative is used in the 5 most similar protocols
The standards and ginger extracts were analyzed on a Shimadzu UPLC system (Nexera X2, Shimadzu, Kyoto, Japan) using the specifications of [30 (link)]: injection volume, 2 μL; flow rate, 0.3 mL/min; retention time, 30 min; wavelength, 280 nm; and eluents, 0.1% acetic acid in water (A) and 0.1% acetic acid in acetonitrile (B). The gradient elution had the following profile: 0–0.5 min, 90% A; 0.5–2.5 min, 60% A; 2.5–4.5 min, 45% A; 4.5–6.0 min, 40% A; 6.0–11.5 min, 35% A; 11.5–13.0 min, 30% A; 13.0–14.5 min, 25% A; 14.5–16.0 min, 20% A; 16.0–17.5 min, 15% A; 17.5–25.0 min, 10% A; 25.0–30.0 min, 90% A. In the UPLC analysis, a Kinetex XB.C18 column (1.7 μm, 150 × 2.1 mm, Phenomenex, Torrnace, CA, USA) was used and the column temperature was maintained at 30 °C. The concentrations in each sample were calculated by comparing their response with the corresponding standard curve. The calibration curve for this method has the six calibration standards solutions (6G, 8G, 10G, 6S, 8S, and 10S) each covering the range of 10–1000 μg/mL (calculation by the equations (R2 coefficients): 6G; y = 942.59x + 16,123 (0.9993), 8G; y = 781.68x + 9155 (0.9994), 10G; y = 752.09x + 10,667 (0.9994), 6S; y = 1103.3x + 13,039 (0.9994), 8S; y = 944.76x + 16,414 (0.9994), 10S; y = 558.24x + 6124 (0.9995)).
+ Open protocol
+ Expand
7

HPLC-MS Analysis of Plant Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The assessment of chemical composition of each extract (RE, LBE) was carried out on a 1260 Infinity chromatograph (Agilent, Santa Clara, CA, USA) consisting of binary pump, a column oven, and photo-diode array (PDA) detector over 55 min period. The separation was performed using a Kinetex XB C18 column (150 × 3 mm, 2.6 µm) (Phenomenex, Torrance, CA, USA). The mobile phase was 0.1% (v/v) FA in water (A) and 0.1% FA in acetonitrile (B). The separation was achieved by a gradient of 0–2 min 1% B; 2–20 min 1–20% B; 20–40 min 20–75% B; 40–45 min 75–95% B; 45–48 min 95% B; 48–49 min 95–1% B; 49–55 min 1% B. The flow rate was 0.5 mL/min and the column temperature was maintained at 25 ± 0.8 °C. The UV–Vis spectra was recorded from 190 to 540 nm with selective wavelength monitoring at 280 nm. Mass spectrometry (MS) detection was carried out on a 6230 MS/TOF mass spectrometer (Agilent, Santa Clara, CA, USA) equipped with an electrospray ionization source with Agilent Jet Stream thermal focusing. The parameters used for ionization source were set as follows: drying and sheath gas flow: 12 L/min; nebulizer: 35 psi; source temperature 350 °C; ion spray voltage 4500 V for the positive mode analysis. The data were collected in 115–1900 m/z range and processing was performed using Mass Hunter qualitative analysis software.
+ Open protocol
+ Expand
8

LC-MS/MS Analysis of Analytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The system used for LC-MS/MS analysis consisted of an ExionLC HPLC system and a Triple Quad 4000 or 4500 tandem mass spectrometer (AB Sciex, Framingham, MA). A 10-µl aliquot of sample was injected for analysis using the peak area ratio of analyte compared to proprietary internal standard (m/z 468.919 → 133.089 IS POS or 467.22 → 85.00 IS NEG). High-performance liquid chromatography separation was accomplished using Kinetex XB-C18 column (2.1 × 50 mm, 5 µm: Phenomenex, Torrance, CA). Mobile phase A consisted of 0.1% formic acid in water, and mobile phase B was 0.1% formic acid in acetonitrile. Analyte-specific gradient conditions and multiple reaction monitoring MS/MS details are presented in Supplemental Table S5.
+ Open protocol
+ Expand
9

Characterization of Organic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
NMR spectra were recorded either in CDCl3 or in DMSO-d6 on a Bruker AVANCE III HD 400 (resonance frequency 400.17 MHz for 1H). Optical rotation was determined using a PolAAr31 polarimeter (Optical Activity Ltd., Ramsey, UK). RP-HPLC separations were performed using an Agilent 1200 Series HPLC system (Agilent Technologies, Santa Clara, CA, USA) equipped with a diode array detector (PAD). Analytical chromatographic separations were carried out either on a Kinetex XB-C18 column (4.6 × 250 mm, 5 μm total particle size; Phenomenex, Torrance, CA, USA; nonpolar compounds) or on a Zorbax Eclipse XDB-C18 column (4.6 × 150 mm; Agilent Technologies, USA; phenolic compounds). Semipreparative RP-HPLC was conducted on a Vertex Plus column (Eurospher II 100-5 C18, 8 × 250 mm; Knauer GmbH, Berlin, Germany), with an isocratic elution, using MeOH-H2O mixtures of different polarities, at a flow rate of 1.0–2.0 mL min−1. The column was coupled to a Knauer P4.1S pump and a dual wavelength UV/VIS detector operating at 210 and 260 nm. Conventional column chromatography was carried out on Silica gel 60 (0.063–0.2 mm, Merck, Germany) and Sephadex LH-20 (GE Healthcare, Uppsala, Sweden). TLC separations were performed using precoated plates (Silica gel 60 without fluorescence indicator, Art. No 5553, Merck, Germany).
+ Open protocol
+ Expand
10

HPLC Purification of Lesion-Containing ODNs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HPLC separations were conducted on an Agilent 1100 HPLC system with a Kinetex XB-C18 column (4.60 × 150 mm, 5 μm in particle size and 100 Å in pore size; Phenomenex Inc., Torrance, CA, USA). For the purification of ODNs, a triethylammonium acetate buffer (50 mM, pH 6.8, Solution A) and a mixture of solution A and acetonitrile (70/30, v/v, Solution B) were employed as mobile phases. The flow rate was 0.8 ml/min and the gradient profile was 5–25% B in 5 min followed by 25–55% B in 60 min. The HPLC traces for the purifications of the 12-mer lesion-containing ODNs are shown in Supplementary Figure S19 and the electrospray ionization-mass spectrometry (ESI-MS) and tandem MS (MS/MS) of the purified lesion-containing ODNs are displayed in Supplementary Figures S20–S26.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!